National Comprehensive Cancer Network. (2015). NCCN Clinical Practice Guidelines in Oncology: Antiemesis [v.2.2015]. Retrieved from http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf
PURPOSE: To provide recommendations for antiemesis in patients with cancer
RESOURCE TYPE: Consensus-based guideline
PHASE OF CARE: Active antitumor treatment
No detailed information about literature searching or evidence grading was provided, and most recommendations were based on low-level evidence and consensus. A panel developed the recommendations.
This guideline provides a good resource for identifying the emetogenicity of various oral and IV chemotherapy agents, and it provides recommendations for radiation-related nausea and vomiting. The guideline is limited in that the full evidence base for all adjuvant recommendations is not provided, and the full strategy for the search and review of evidence is not stated.